KR20240052833A - 화합물, 화합물의 염, 항체 수식 시약, 수식 항체의 제조 방법 및 수식 항체 - Google Patents

화합물, 화합물의 염, 항체 수식 시약, 수식 항체의 제조 방법 및 수식 항체 Download PDF

Info

Publication number
KR20240052833A
KR20240052833A KR1020247011055A KR20247011055A KR20240052833A KR 20240052833 A KR20240052833 A KR 20240052833A KR 1020247011055 A KR1020247011055 A KR 1020247011055A KR 20247011055 A KR20247011055 A KR 20247011055A KR 20240052833 A KR20240052833 A KR 20240052833A
Authority
KR
South Korea
Prior art keywords
igg
compound
group
formula
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247011055A
Other languages
English (en)
Korean (ko)
Inventor
유지 이토
다쿠 요시야
슈고 츠다
Original Assignee
가고시마 유니버시티
가부시키가이샤 페프치도 겐큐쇼
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 가고시마 유니버시티, 가부시키가이샤 페프치도 겐큐쇼 filed Critical 가고시마 유니버시티
Publication of KR20240052833A publication Critical patent/KR20240052833A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/88—Carboxylic acid amides having nitrogen atoms of carboxamide groups bound to an acyclic carbon atom and to a carbon atom of a six-membered aromatic ring wherein at least one ortho-hydrogen atom has been replaced
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
KR1020247011055A 2021-09-08 2022-09-08 화합물, 화합물의 염, 항체 수식 시약, 수식 항체의 제조 방법 및 수식 항체 Pending KR20240052833A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2021-146504 2021-09-08
JP2021146504 2021-09-08
PCT/JP2022/033713 WO2023038082A1 (ja) 2021-09-08 2022-09-08 化合物、化合物の塩、抗体修飾試薬、修飾抗体の製造方法及び修飾抗体

Publications (1)

Publication Number Publication Date
KR20240052833A true KR20240052833A (ko) 2024-04-23

Family

ID=85506405

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247011055A Pending KR20240052833A (ko) 2021-09-08 2022-09-08 화합물, 화합물의 염, 항체 수식 시약, 수식 항체의 제조 방법 및 수식 항체

Country Status (9)

Country Link
US (1) US20250304617A1 (https=)
EP (1) EP4400509A1 (https=)
JP (1) JPWO2023038082A1 (https=)
KR (1) KR20240052833A (https=)
CN (1) CN117916251A (https=)
AU (1) AU2022342928A1 (https=)
CA (1) CA3231257A1 (https=)
TW (1) TW202328163A (https=)
WO (1) WO2023038082A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026058917A1 (ja) * 2024-09-10 2026-03-19 味の素株式会社 抗体親和性物質を含む化合物、修飾抗体およびそれらの塩ならびに抗体誘導体または抗体－機能性物質コンジュゲートの製造方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016186206A1 (ja) 2015-05-20 2016-11-24 国立大学法人鹿児島大学 ＩｇＧ結合ペプチドによる抗体の特異的修飾
WO2017217347A1 (ja) 2016-06-13 2017-12-21 国立大学法人鹿児島大学 ＩｇＧ結合ペプチドによる部位特異的ＲＩ標識抗体
WO2018199337A1 (ja) 2017-04-28 2018-11-01 味の素株式会社 可溶性タンパク質に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩
WO2018230257A1 (ja) 2017-06-16 2018-12-20 国立大学法人鹿児島大学 ＩｇＧ結合ペプチド、及び該ペプチドによる抗体の特異的修飾

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054030A1 (fr) 2006-11-02 2008-05-08 Kagoshima University Peptide liant l'igg
JP5994068B2 (ja) 2011-08-24 2016-09-21 国立大学法人 鹿児島大学 ＩｇＧ結合性ペプチド及びそれによるＩｇＧの検出および精製方法
TWI886164B (zh) * 2019-10-24 2025-06-11 國立大學法人鹿兒島大學 1價ccap生成物之製造方法
JP7461180B2 (ja) 2020-03-16 2024-04-03 五洋建設株式会社 プレキャスト部材の鉄筋挿入孔の形成方法、プレキャスト部材の接合方法およびプレキャスト部材の製造方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016186206A1 (ja) 2015-05-20 2016-11-24 国立大学法人鹿児島大学 ＩｇＧ結合ペプチドによる抗体の特異的修飾
WO2017217347A1 (ja) 2016-06-13 2017-12-21 国立大学法人鹿児島大学 ＩｇＧ結合ペプチドによる部位特異的ＲＩ標識抗体
WO2018199337A1 (ja) 2017-04-28 2018-11-01 味の素株式会社 可溶性タンパク質に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩
WO2018230257A1 (ja) 2017-06-16 2018-12-20 国立大学法人鹿児島大学 ＩｇＧ結合ペプチド、及び該ペプチドによる抗体の特異的修飾

Also Published As

Publication number Publication date
EP4400509A1 (en) 2024-07-17
US20250304617A1 (en) 2025-10-02
AU2022342928A1 (en) 2024-03-28
JPWO2023038082A1 (https=) 2023-03-16
WO2023038082A1 (ja) 2023-03-16
CA3231257A1 (en) 2023-03-16
CN117916251A (zh) 2024-04-19
TW202328163A (zh) 2023-07-16

Similar Documents

Publication Publication Date Title
JP7417432B2 (ja) 新規リンカー、その製造方法およびその応用
US11472865B2 (en) IgG-binding peptide, and specific modification of antibody with said peptide
KR102511249B1 (ko) 신규한 안정한 항체-약물 복합체, 이의 제조방법 및 이의 용도
ES3058443T3 (es) Modificación específica de anticuerpo con péptido de unión a IgG
JP6585600B2 (ja) Ｃ末端軽鎖ポリペプチド伸長を含有する抗体、ならびにその複合体及びその使用方法
JP7680745B2 (ja) １価ｃｃａｐ生成物の製造方法
US20180028682A1 (en) Maytansine-drug conjugates of her-2 specific binding proteins generated by site specific sortase-enzyme mediated conjugation
JP2018502045A (ja) タンパク薬物複合体で使用するためのリンカーに関連する材料および方法
KR20240052833A (ko) 화합물, 화합물의 염, 항체 수식 시약, 수식 항체의 제조 방법 및 수식 항체
CN101312986A (zh) 生产修饰（多）肽的方法
Perols et al. Site‐Specific Antibody Labeling by Covalent Photoconjugation of Z Domains Functionalized for Alkyne–Azide Cycloaddition Reactions
JP7782851B2 (ja) ペプチド架橋剤及び当該架橋剤で架橋された架橋ペプチド
HK40109611A (zh) 化合物、化合物的盐、抗体修饰试剂、修饰抗体的制造方法及修饰抗体
EA051199B1 (ru) Сшивающий агент для пептида и сшитый пептид, который сшивают с использованием указанного сшивающего агента
US20260021213A1 (en) Method for producing fc-containing molecule modifying reagent
US11484596B2 (en) Optimized process for dimeric peptide-phospholipid conjugate
CN118922433A (zh) 含Fc分子修饰试剂的制造方法
HK40065797A (zh) 1价ccap生成物的制造方法

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20240402

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250630

Comment text: Request for Examination of Application